| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hung David | PRESIDENT AND CEO, Director, 10%+ Owner | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 18 Jun 2025 | 0001310880 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Purchase | $893,500 | +500,000 | +0.85% | $1.79 | 59,281,054 | 16 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | ) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |